Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
34 studies found for:    " March 11, 2009":" April 10, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Active, not recruiting Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men
Condition: HIV Infections
Interventions: Biological: DNA plasmid vaccine;   Biological: Recombinant adenoviral serotype 5 (rAD5) vector vaccine;   Biological: DNA vaccine placebo;   Biological: HIV-1 recombinant adenovirus vaccine placebo
2 Completed
Has Results
Study of the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: Stribild;   Drug: Atripla
3 Completed A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Maraviroc Therapy
Condition: HIV Infections
Interventions: Drug: maraviroc in combination with 2 NRTIs (dual nucleoside reverse transcriptase inhibitor);   Drug: maraviroc plus raltegravir in combination with 2 NRTIs (dual nucleoside reverse transcriptase inhibitor);   Drug: efavirenz [or other NNRTI (non-nucleoside reverse transcriptase inhibitor)]
4 Completed Motiv82Change: an HIV Prevention Study for Young Latino Men
Condition: HIV Infections
Intervention: Behavioral: Entre Culturas: Navigating Culture, Identity, and HIV Risk
5 Completed Determining Characteristics and Behaviors of Adolescent Women Regarding HIV Risk and Microbicide Trial Participation
Condition: HIV Infections
Intervention:
6 Completed Raltegravir and Atazanavir Dosing Strategy Study
Condition: HIV Infection
Intervention: Drug: atazanavir plus raltegravir
7 Completed Maraviroc Immune Recovery Study
Condition: HIV Infections
Interventions: Drug: maraviroc;   Drug: Placebo
8 Completed Disulfiram Interactions With HIV Medications: Clinical Implications
Conditions: HIV Infections;   Drug Abuse
Interventions: Drug: Disulfiram;   Drug: Disulfiram + Efavirenz;   Drug: Disulfiram + Atazanavir;   Drug: Disulfiram + Ritonavir
9 Completed Measurement of Adherence to ART in HIV-Infected Children in Uganda (The CHARTA Study)
Conditions: HIV;   HIV Infections
Intervention:
10 Completed Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications
Conditions: Opioid Dependency;   HIV Infections
Interventions: Drug: Fosamprenavir/Ritonavir;   Drug: Darunavir/Ritonavir;   Drug: Rifampin;   Drug: Rifabutin;   Drug: Buprenorphine
11 Completed
Has Results
Non-Interventional Observational Study With Viramune Plus Antiretroviral in HIV Infected Patients
Condition: HIV Infections
Intervention:
12 Completed Asha HIV Health Promotion Intervention in India
Condition: HIV Infections
Interventions: Behavioral: ASHA LIFE;   Behavioral: USUAL Care
13 Completed Treatment De-Intensification and Residual HIV-1 in Youth
Conditions: HIV-1;   HIV Infections
Intervention: Other: Blood draw
14 Unknown  Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients
Conditions: Acquired Immune Deficiency Syndrome;   HIV Infections
Interventions: Drug: first line ARV (3TC+NVP+D4T or 3TC+NVP+AZT);   Drug: second line ARV therapy (3TC+TDF+LPV/RTV)
15 Completed Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC
Conditions: HIV Infection;   HIV Infections
Interventions: Drug: AZT+3TC+ABV (Trizivir);   Drug: Switching to LPV/r monotherapy (Kaletra)
16 Completed
Has Results
Combination Pain Therapy in HIV Neuropathy
Conditions: HIV Infections;   Peripheral Neuropathy
Interventions: Drug: Duloxetine;   Drug: Duloxetine placebo;   Drug: Methadone;   Drug: Methadone placebo
17 Active, not recruiting Strategic Timing of Antiretroviral Treatment
Condition: HIV Infection
Intervention: Drug: All licensed antiretroviral medications
18 Withdrawn Raltegravir Activity In Lymphoid Tissues
Conditions: HIV Infection;   HIV Infections
Interventions: Drug: Efavirenz + Tenofovir DF/Emtricitabine;   Drug: Raltegravir + Tenofovir DF/Emtricitabine;   Procedure: Colonoscopy with biopsies;   Procedure: Inguinal Lymph Node Excision
19 Completed Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected Adults
Conditions: HIV Infections;   Malaria
Intervention: Drug: Artemether/Lumefantrine
20 Completed Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals
Conditions: HIV Infection;   HIV Infections
Intervention: Behavioral: Adherence report

   Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.